Core Viewpoint - Bank of America (BAC) is positioned for growth with a positive outlook supported by strong fourth-quarter results and a favorable price target from Truist Financial, indicating a potential price increase. Financial Performance - Bank of America reported strong fourth-quarter results for 2025, exceeding expectations in both revenue and earnings per share, particularly in consumer banking and wealth management divisions [2][5] - The bank's credit quality remains resilient, with provisions for credit losses significantly lower than anticipated, indicating a positive sign for investors [3] Growth Projections - Management forecasts a 6% growth in net interest income for 2026, driven by the repricing of fixed-rate assets and steady loan growth, aligning with the optimistic price target set by Truist Financial [3][5] Stock Performance - Currently, BAC's stock price is $52.48, reflecting a decrease of 3.78% or $2.06, with fluctuations between a low of $51.66 and a high of $53.48 on the day [4] - Over the past year, BAC has reached a high of $57.55 and a low of $33.07, with a market capitalization of approximately $383.24 billion [4]

Market Overview - The S&P 500 has shown significant gains, registering a 16% increase in 2025, following a 24% rise in 2023 and a 23% rise in 2024, totaling approximately 80% over the past three years, marking the strongest three-year performance since a 90% surge from 2019 to 2021 [1][2]. Economic Forecast - A Financial Times survey predicts a 10% gain in the S&P 500 for 2026, with all surveyed banks expecting the index to surpass 7,500 [2]. - Goldman Sachs anticipates a 12% rally in 2026, driven by earnings growth supported by a strong economy and Federal Reserve rate cuts [2][3]. Stock Valuation Insights - Ben Snider from Goldman Sachs highlights that double-digit profit growth and improved productivity from AI position the market for continued bullish trends, although high stock valuations could pose risks if earnings fall short [3][4]. Stock Selection Methodology - The article identifies U.S.-based stocks with market capitalizations of at least $2 billion that have increased by at least 20% over the past three months, further narrowing the list to those with a 50-day moving average above a 200-day moving average [6]. - The final selection includes 14 stocks with the highest average upside potential, based on data as of January 12, 2026, and includes hedge fund holdings as of Q3 2025 for additional investor interest insights [6][7]. Featured Stocks Alphatec Holdings, Inc. (NASDAQ: ATEC) - Projected revenue for 2026 is between $890 million, with 90% expected to be surgical-related, and adjusted EBITDA anticipated at around $130 million [10]. - The company reported a 25% increase in total revenue for 2025, driven by a 26% surge in surgical revenue, and ended the year with a cash balance of $161 million [9]. - Wall Street has a consensus Strong Buy rating with a one-year average share price target of $24.55, indicating an upside of nearly 40% [12]. Terns Pharmaceuticals, Inc. (NASDAQ: TERN) - The stock has surged over 300% in the past three months, with analysts projecting a further 42.31% upside based on a one-year average share price target of $53.75 [16]. - The company received a Buy rating from Truist Financial, with a price target raised to $56 following positive Phase 1 study results for its lead program targeting chronic myeloid leukemia [14][15]. - Mizuho Securities also reiterated an Outperform rating, indicating strong potential for TERN-701 as a leading treatment for CML [15].

Core Insights - Zebra Technologies is a key player in the industrial products sector, specializing in automatic identification and data capture solutions, including barcode scanners, mobile computers, and printers [1] - The stock price target set by Jamie Cook from Truist Financial is $291, indicating a potential increase of approximately 14.47% from the current trading price of $254.23 [2][6] - Institutional investor sentiment is mixed, with Corient Private Wealth LLC reducing its stake by 12.2%, while Vanguard Group Inc. and State Street Corp have increased their holdings, reflecting a positive outlook from some investors [3][4][6] Company Performance - Zebra Technologies is currently trading at $256.11, showing a slight increase of approximately 0.72% or $1.84 [5][6] - The stock has fluctuated between $253.81 and $259.09 in recent trading, with a market capitalization of approximately $12.97 billion [5][6] - Over the past year, the stock reached a high of $427.76 and a low of $205.73, indicating significant volatility [5]

Core Viewpoint - Dollar General Corporation (NYSE:DG) is viewed positively by investors, with a potential upside of 21% according to market analysts, despite a minimal downside of 0.11% based on average price targets [1]. Financial Performance - Dollar General reported Q3 sales of $10.65 billion, reflecting a 2.5% increase, which aligns with market expectations [2]. - The company's earnings per share (EPS) of $1.28 exceeded Truist's estimate of $0.96, indicating stronger profitability than anticipated [2]. Growth Drivers - The increase in earnings is attributed to reduced shrinkage, larger markups, and a modest boost from hurricane-related buying [3]. - Sales growth has returned to a 2-3% pace after facing challenges in 2023 and 2024 [3]. Margin Improvement - Improved margins this year are a result of diminished inventory, SKU optimization initiatives, and lower shrinkage [4]. - Despite the positive financial results, Truist maintains a Hold recommendation due to anticipated tough margin comparisons in the upcoming year [4].

Company Overview - Arthur J. Gallagher & Co. (NYSE:AJG) is a leading global insurance brokerage and risk management services firm, competing with major players like Marsh & McLennan and Aon [1] - AJG offers a comprehensive range of insurance and consulting services to clients worldwide [1] Stock Performance - The current stock price of AJG is $251.64, experiencing a decrease of 1.78% or $4.55 [3] - The stock has fluctuated between a low of $249.54 and a high of $256.64 during the trading day [3] - Over the past year, AJG has seen a high of $351.23 and a low of $236.34, showcasing its volatility [3] - AJG has a market capitalization of approximately $64.62 billion and a trading volume today of 1,400,337 shares [3][4] Analyst Insights - Truist Financial has set a price target of $280 for AJG, indicating a potential upside of 11.39% from its current trading price [4] - B. Riley Wealth Advisors Inc. has acquired a new stake in AJG, purchasing 3,622 shares valued at approximately $1.16 million, reflecting confidence in the company's future performance [2] - Advisory Services Network LLC increased its holdings in AJG by 3.4%, while Pitcairn Co. boosted its position by 20.7% during the second quarter, indicating a trend of institutional investment adjustments [2]

Company Overview - Vornado Realty Trust (NYSE:VNO) is a significant real estate investment trust (REIT) focusing on office and retail properties, primarily in urban areas, with a notable presence in New York City [1] - The company competes with other major REITs such as Boston Properties and SL Green Realty [1] Investment Insights - On December 15, 2025, Michael Lewis from Truist Financial set a price target of $36 for VNO, indicating a potential upside of approximately 3.12% from its trading price of $34.91 at that time [2] - This price target was revised down from a previous target of $40, reflecting a more cautious outlook on the stock [2] Shareholder Activity - Resolution Capital Ltd increased its investment in Vornado by acquiring an additional 4,084,815 shares valued at approximately $168.53 million during the third quarter, raising its total holding to 5,380,978 shares valued at $218.09 million as of September 30, 2025 [3] Stock Performance - Despite the recent price target adjustment, Vornado's stock price has seen a slight decrease, currently at $34.84, reflecting a 1.44% drop with a change of $0.51 [4] - The stock has traded between $34.65 and $35.68 today, indicating some volatility in its price movements [4] - Vornado's market capitalization is approximately $6.69 billion, with a trading volume of 493,391 shares on the NYSE [5] - Over the past year, the stock has experienced a high of $45.53 and a low of $29.68, showcasing a wide range of price fluctuations [5] - Resolution Capital's investment in Vornado now constitutes 4.24% of its $5.14 billion in reportable U.S. equity assets [5]

Core Viewpoint - Arcus Biosciences, Inc. is facing challenges following the discontinuation of its Phase 3 STAR-221 study, which has negatively impacted investor sentiment and stock performance, despite a previously strong market position. Group 1: Stock Performance - Truist Financial has set a price target of $30 for Arcus Biosciences (RCUS), indicating a potential upside of 34.74% from its current trading price of $22.27 [1][5] - Following the announcement of the study's discontinuation, RCUS stock experienced a significant decline, dropping to $21.77, a decrease of 13.42% or $3.38 from its previous value [2][3] - The stock fluctuated between $20.35 and $24 during the trading day, reflecting market volatility [3] Group 2: Study Discontinuation - Arcus announced the discontinuation of its Phase 3 STAR-221 study in collaboration with Gilead Sciences, as the Independent Data Monitoring Committee found no improvement in overall survival with the tested combination [2][5] - The decision to halt the study has adversely affected investor sentiment, despite the safety profiles being similar [2] Group 3: Future Focus - Arcus is shifting its focus to research and development investments in Casdatifan and its emerging inflammation and immunology portfolio [4][5] - The company's market capitalization is approximately $2.35 billion, with a trading volume of 5,619,062 shares on the day of the announcement [4]

Group 1: Omnicom - Omnicom has become the world's largest marketing company following its acquisition of the Interpublic Group [2] - The company announced a 14% increase in its quarterly dividend, which will be paid on January 9th, resulting in a stock yield of 4.4% [2] - The stock is currently trading at a 37% discount to its Morning Star fair value estimate of $115 [2] Group 2: McCormick - McCormick is the leader in the global spices and herbs market and is recognized as a dividend aristocrat with its 40th consecutive annual dividend increase [3] - The stock yields 2.9% with an annualized dividend growth of 8.1% over the past 5 years [3] - Morning Star analysts expect similar growth in the future, forecasting high single-digit annual dividend increases and a payout ratio near 60% [4] Group 3: Truist Financial - Truist Financial, formed by the merger of BB&T and Suntrust, is one of the three super regional banks in the US [4] - The stock yields 4.5%, slightly above the 4.3% average over the past 5 years, with an annualized dividend growth of 4% [5] - Although the dividend has remained flat for the past 14 quarters, analysts expect the payout ratio to trend down below 50% as earnings increase, with modest dividend growth anticipated starting in 2027 [6]

Core Viewpoint - PennantPark Floating Rate Capital Ltd. (NYSE:PFLT) is highlighted as a strong growth stock, with a Buy recommendation and a price target of $11 from Truist Financial [1]. Financial Performance - For the quarter ended September 30, 2025, PennantPark allocated $633 million towards 116 portfolio holdings, with an average yield of 10.5% on debt investments [2]. - The company reported sales and repayments of investments totaling $256.2 million for the same quarter [2]. - Investment income for the three months and year ended September 30, 2025, was $69 million and $261.4 million, respectively, primarily from first lien secured debt and other investments [3]. Company Overview - PennantPark Floating Rate Capital Ltd. is a business development company that focuses on investing in floating rate loans and other debt or equity of middle-market companies, mainly in the United States [3].

Core Viewpoint - Goldman Sachs has launched a new investment portfolio, GSXUPROD, consisting of non-tech companies that have integrated AI into their workflows to reduce costs and improve profit margins. The firm believes that this portfolio has the potential for higher earnings per share changes compared to the Russell 1000 and S&P 500 indices due to AI adoption and productivity enhancements [1][3][7]. Group 1: AI Adoption in Various Industries - The adoption rate of AI in enterprises has reached 37%, with large companies showing a 13% adoption rate based on stricter definitions [5]. - Financial institutions are deploying AI to enhance operational efficiency across various applications, including fraud detection and customer interaction [8]. - Retailers and warehouse operators are utilizing AI for optimizing customer experiences, supply chain logistics, and internal operations, leading to significant productivity improvements [14][15]. Group 2: Specific Company Initiatives - JPMorgan Chase emphasizes its pre-existing AI expertise and uses AI to control workforce growth while maintaining cost discipline [9]. - Bank of America views AI as "augmented intelligence," with its Erica platform handling 2 million customer interactions daily [11]. - Amazon is heavily investing in AI across multiple domains, including AWS AI services and custom chips [14]. - HCA Healthcare is implementing AI to improve revenue cycle management and enhance clinical documentation [25]. - Yum Brands has deployed AI in over 28,000 restaurants to provide operational guidance and improve efficiency [27]. Group 3: Performance and Market Outlook - The GSXUPROD portfolio has underperformed the market this year, even when excluding the seven tech giants, but still shows potential for higher earnings per share changes due to AI integration [7]. - Goldman Sachs believes that the long-term investment opportunity lies in AI productivity beneficiaries, which will be crucial in 2026 [3].